Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase

Molecular Oncology

Volumn 9, Issue 1, 2015, Pages 192-203

  Carruthers, Ross ^a   Ahmed, Shafiq U ^a   Strathdee, Karen ^a   Gomez Roman, Natividad ^a   Amoah Buahin, Evelyn ^b   Watts, Colin ^c   Chalmers, Anthony J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GHANA   (Ghana)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ATM; Cancer stem cells; DNA damage response; Glioblastoma; Radiotherapy

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; ATM PROTEIN; 2-MORPHOLIN-4-YL-6-THIANTHREN-1-YL-PYRAN-4-ONE; ATM PROTEIN, HUMAN; MORPHOLINE DERIVATIVE; PYRONE DERIVATIVE; RADIOSENSITIZING AGENT; TUMOR PROTEIN;

ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENZYME INHIBITION; G2 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; RADIOSENSITIZATION; TUMOR CELL; UPREGULATION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GAMMA RADIATION; M PHASE CELL CYCLE CHECKPOINT; MALE; METABOLISM; PATHOLOGY; RADIATION RESPONSE; RADIATION TOLERANCE; TUMOR CELL CULTURE;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GAMMA RAYS; GLIOBLASTOMA; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MALE; MORPHOLINES; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PYRONES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 84920479791     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.08.003     Document Type: Article

References (44)

1. Alvarez-Quilon A., Serrano-Benitez A., Lieberman J.A., Quintero C., Sanchez-Gutierrez D., Escudero L.M., Cortes-Ledesma F. ATM specifically mediates repair of double-strand breaks with blocked DNA ends. Nat. Commun. 2014, 5:3347.
2. Banath J.P., Macphail S.H., Olive P.L. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res. 2004, 64:7144-7149.
3. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
4. Bartkova J., Hamerlik P., Stockhausen M.T., Ehrmann J., Hlobilkova A., Laursen H., Kalita O., Kolar Z., Poulsen H.S., Broholm H., Lukas J., Bartek J. Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas. Oncogene 2010, 29:5095-5102.
5. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Orntoft T., Lukas J., Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005, 434:864-870.
6. Beier D., Hau P., Proescholdt M., Lohmeier A., Wischhusen J., Oefner P.J., Aigner L., Brawanski A., Bogdahn U., Beier C.P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007, 67:4010-4015.
7. Biddlestone-Thorpe L., Sajjad M., Rosenberg E., Beckta J.M., Valerie N.C., Tokarz M., Adams B.R., Wagner A.F., Khalil A., Gilfor D., Golding S.E., Deb S., Temesi D.G., Lau A., O'Connor M.J., Choe K.S., Parada L.F., Lim S.K., Mukhopadhyay N.D., Valerie K. ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation. Clin. Cancer Res.: An Official Journal of the American Association for Cancer Research 2013, 19:3189-3200.
8. Bjork-Eriksson T., West C., Karlsson E., Mercke C. Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 2000, 46:13-19.
9. Bjork-Eriksson T., West C.M., Karlsson E., Slevin N.J., Davidson S.E., James R.D., Mercke C. The invitro radiosensitivity of human head and neck cancers. Br. J. Cancer 1998, 77:2371-2375.
10. Bonavia R., Inda M.M., Cavenee W.K., Furnari F.B. Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 2011, 71:4055-4060.
11. Burma S., Chen B.P., Murphy M., Kurimasa A., Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J.Biol. Chem. 2001, 276:42462-42467.
12. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., Parada L.F. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
13. Fael Al-Mayhani T.M., Ball S.L., Zhao J.W., Fawcett J., Ichimura K., Collins P.V., Watts C. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. J.Neurosci. Methods 2009, 176:192-199.
14. Fokas E., Prevo R., Hammond E.M., Brunner T.B., McKenna W.G., Muschel R.J. Targeting ATR in DNA damage response and cancer therapeutics. Cancer Treat. Rev. 2014, 40:109-117.
15. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64:7011-7021.
16. Golding S.E., Rosenberg E., Adams B.R., Wignarajah S., Beckta J.M., O'Connor M.J., Valerie K. Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control. Cell Cycle 2012, 11:1167-1173.
17. Golding S.E., Rosenberg E., Valerie N., Hussaini I., Frigerio M., Cockcroft X.F., Chong W.Y., Hummersone M., Rigoreau L., Menear K.A., O'Connor M.J., Povirk L.F., van Meter T., Valerie K. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion. Mol. Cancer Ther. 2009, 8:2894-2902.
18. Goldstein M., Derheimer F.A., Tait-Mulder J., Kastan M.B. Nucleolin mediates nucleosome disruption critical for DNA double-strand break repair. Proc. Natl. Acad. Sci. USA 2013, 110:16874-16879.
19. Goodarzi A.A., Jeggo P., Lobrich M. The influence of heterochromatin on DNA double strand break repair: getting the strong, silent type to relax. DNA Repair 2010, 9:1273-1282.
20. Goodarzi A.A., Noon A.T., Deckbar D., Ziv Y., Shiloh Y., Lobrich M., Jeggo P.A. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol. Cell 2008, 31:167-177.
21. Gosink E.C., Chong M.J., McKinnon P.J. Ataxia telangiectasia mutated deficiency affects astrocyte growth but not radiosensitivity. Cancer Res. 1999, 59:5294-5298.
22. Joo K.M., Kim S.Y., Jin X., Song S.Y., Kong D.S., Lee J.I., Jeon J.W., Kim M.H., Kang B.G., Jung Y., Jin J., Hong S.C., Park W.Y., Lee D.S., Kim H., Nam D.H. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab. Invest.: A Journal of Technical Methods and Pathology 2008, 88:808-815.
23. Kelly J.J., Stechishin O., Chojnacki A., Lun X., Sun B., Senger D.L., Forsyth P., Auer R.N., Dunn J.F., Cairncross J.G., Parney I.F., Weiss S. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells 2009, 27:1722-1733.
24. Kinner A., Wu W., Staudt C., Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008, 36:5678-5694.
25. Kuhne M., Riballo E., Rief N., Rothkamm K., Jeggo P.A., Lobrich M. A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity. Cancer Res. 2004, 64:500-508.
26. Mannino M., Gomez-Roman N., Hochegger H., Chalmers A.J. Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors: implications for stem cell mitosis and centrosome dynamics. Stem Cell Res. 2014, 13:135-143.
27. McCord A.M., Jamal M., Williams E.S., Camphausen K., Tofilon P.J. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin. Cancer Res.: An Official Journal of the American Association for Cancer Research 2009, 15:5145-5153.
28. Nowell P.C. The clonal evolution of tumor cell populations. Science 1976, 194:23-28.
29. Patel A.P., Tirosh I., Trombetta J.J., Shalek A.K., Gillespie S.M., Wakimoto H., Cahill D.P., Nahed B.V., Curry W.T., Martuza R.L., Louis D.N., Rozenblatt-Rosen O., Suva M.L., Regev A., Bernstein B.E. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 2014, 344:1396-1401.
30. Raso A., Vecchio D., Cappelli E., Ropolo M., Poggi A., Nozza P., Biassoni R., Mascelli S., Capra V., Kalfas F., Severi P., Frosina G. Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein. Brain Pathol. 2012, 22:677-688.
31. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
32. Riballo E., Kuhne M., Rief N., Doherty A., Smith G.C., Recio M.J., Reis C., Dahm K., Fricke A., Krempler A., Parker A.R., Jackson S.P., Gennery A., Jeggo P.A., Lobrich M. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol. Cell 2004, 16:715-724.
33. Ropolo M., Daga A., Griffero F., Foresta M., Casartelli G., Zunino A., Poggi A., Cappelli E., Zona G., Spaziante R., Corte G., Frosina G. Comparative analysis of DNA repair in stem and nonstem glioma cell cultures. Mol. Cancer Res.: MCR 2009, 7:383-392.
34. Schneider L., Fumagalli M., d'Adda di Fagagna F. Terminally differentiated astrocytes lack DNA damage response signaling and are radioresistant but retain DNA repair proficiency. Cell Death Differ. 2012, 19:582-591.
35. Schwager F. Irreparable dna double strand dna breaks induced in eukaryotic cells by sparsely or densely ionizing radiation and their importance for cell killing. Mutat. Res. 1982, 96.
36. Sedelnikova O.A., Rogakou E.P., Panyutin I.G., Bonner W.M. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat. Res. 2002, 158:486-492.
37. Shiloh Y., Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol. 2013, 14:197-210.
38. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
39. Son M.J., Woolard K., Nam D.H., Lee J., Fine H.A. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009, 4:440-452.
40. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N.Engl. J. Med. 2005, 352:987-996. European Organisation for, R., Treatment of Cancer Brain, T., Radiotherapy, G., National Cancer Institute of Canada Clinical Trials, G.
41. Taylor A.M., Harnden D.G., Arlett C.F., Harcourt S.A., Lehmann A.R., Stevens S., Bridges B.A. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 1975, 258:427-429.
42. Venere M., Hamerlik P., Wu Q., Rasmussen R.D., Song L.A., Vasanji A., Tenley N., Flavahan W.A., Hjelmeland A.B., Bartek J., Rich J.N. Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells. Cell Death Differ. 2014, 21:258-269.
43. West C.M., Davidson S.E., Roberts S.A., Hunter R.D. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br. J. Cancer 1997, 76:1184-1190.
44. Xu B., Kim S.T., Lim D.S., Kastan M.B. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol. Cell. Biol. 2002, 22:1049-1059.